Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil

Journal of Infection

Volumn 67, Issue 3, 2013, Pages 247-249

  Tuon, Felipe F ^a,b   Rocha, Jaime L ^c   Formighieri, Marina S ^b   Sfair, Samiria ^b   Bertoldi, Mariana B ^b   Palmeiro, Jussara Kasuko ^a   Dalla Costa, Libera Maria ^a,d  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^c Division of Microbiology   (Brazil)

^d INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE KPC 2; ERTAPENEM; FOSFOMYCIN; MEROPENEM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIURIA; BRAZIL; DRUG RESISTANCE, BACTERIAL; FOSFOMYCIN; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; RECTUM; THIENAMYCINS;

EID: 84881030864     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.04.017     Document Type: Letter

References (8)

1. Bleumin D., Cohen M.J., Moranne O., Esnault V.L., Benenson S., Paltiel O., et al. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. JInfect 2012, 65:318-325.
2. Zhang R., Cai J.C., Zhou H.W., Nasu M., Chen G.X. Genotypic characterization and invitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems. J Med Microbiol 2011, 60:1813-1819.
3. Biondo C.M., Rocha J.L., Tuon F.F. Fosfomycin invitro resistance of Escherichia coli from the community. Braz J Infect Dis 2011, 15:96.
4. Tuon F.F., Rocha J.L., Toledo P., Arend L.N., Dias C.H., Leite T.M., et al. Risk factors for KPC-producing Klebsiella pneumoniae bacteremia. Braz J Infect Dis 2012, 16:416-419.
5. Lu C.L., Liu C.Y., Huang Y.T., Liao C.H., Teng L.J., Turnidge J.D., et al. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrobial Agents Chemother 2011, 55:4295-4301.
6. CLSI Performance standards for antimicrobial susceptibility testing 2012, Clinical and Laboratory Standards Institute.
7. Endimiani A., Patel G., Hujer K.M., Swaminathan M., Perez F., Rice L.B., et al. Invitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrobial Agents Chemother 2010, 54:526-529.
8. Calbo E., Romani V., Xercavins M., Gomez L., Vidal C.G., Quintana S., et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 2006, 57:780-783.